Literature DB >> 6281794

gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors.

J Hawiger, S Timmons, M Kloczewiak, D D Strong, R F Doolittle.   

Abstract

Fibrinogen, a clottable plasma protein, agglutinates both prokaryotic cells (e.g., staphylococci) and eukaryotic cell fragments (e.g., platelets) through interaction with specific receptors. To identify the region of the fibrinogen molecule responsible for its interaction with human platelets, we prepared polypeptide chain subunits (alpha, beta, and gamma) of human fibrinogen by reduction and carboxymethylation. A mixture of the chains induced aggregation (clumping) of human platelets separated from plasma proteins and treated with ADP. When individual chains of fibrinogen were tested, gamma-chain multimers caused platelet aggregation at a molar concentration comparable with that of intact human fibrinogen. The beta chain remained inactive, and the alpha chain was 1/4th to 1/5th as reactive as the gamma chain. Monospecific antibody fragments against the gamma chain inhibited binding of 125I-labeled fibrinogen to the human platelet receptor and blocked aggregation of platelets induced by ADP in the presence of fibrinogen or gamma-chain multimers. These results indicate that the gamma chain of human fibrinogen bears the main site for interaction with the platelet receptor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281794      PMCID: PMC346124          DOI: 10.1073/pnas.79.6.2068

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: amino-terminal sequences of intermediate and terminal fragments.

Authors:  T Takagi; R F Doolittle
Journal:  Biochemistry       Date:  1975-03-11       Impact factor: 3.162

2.  Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.

Authors:  J Hawiger; S Niewiarowski; V Gurewich; D P Thomas
Journal:  J Lab Clin Med       Date:  1970-01

3.  - cross-linking sites in human and bovine fibrin.

Authors:  R Chen; R F Doolittle
Journal:  Biochemistry       Date:  1971-11-23       Impact factor: 3.162

4.  Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia.

Authors:  H J Weiss; J Rogers
Journal:  N Engl J Med       Date:  1971-08-12       Impact factor: 91.245

5.  Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation.

Authors:  S Niewiarowski; A Z Budzynski; B Lipinski
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

6.  Amino acid sequence studies on the alpha chain of human fibrinogen. Characterization of 11 cyanogen bromide fragments.

Authors:  R F Doolittle; K G Cassman; B A Cottrell; S J Friezner; J T Hucko; T Takagi
Journal:  Biochemistry       Date:  1977-04-19       Impact factor: 3.162

7.  Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.

Authors:  C S Jenkins; D Meyer; M D Dreyfus; M J Larrieu
Journal:  Br J Haematol       Date:  1974-12       Impact factor: 6.998

8.  Amino acid sequence of the carboxy-terminal cyanogen bromide peptide of the human fibrinogen beta-chain: homology with the corresponding gamma-chain peptide and presence in fragment D.

Authors:  T Takagi; R F Doolittle
Journal:  Biochim Biophys Acta       Date:  1975-04-29

9.  Fibrinogen heterogeneity in human plasma. Electrophoretic demonstration and characterization of two major fibrinogen components.

Authors:  I Lipinska; B Lipinski; V Gurewich
Journal:  J Lab Clin Med       Date:  1974-10

10.  Amino acid sequence studies on artiodactyl fibrinopeptides. I. Dromedary camel, mule deer, and cape buffalo.

Authors:  R F Doolittle; D Schubert; S A Schwartz
Journal:  Arch Biochem Biophys       Date:  1967-02       Impact factor: 4.013

View more
  22 in total

1.  Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling.

Authors:  Roy R Hantgan; Mary C Stahle; John H Connor; David A Horita; Mattia Rocco; Mary A McLane; Sergiy Yakovlev; Leonid Medved
Journal:  Protein Sci       Date:  2006-08       Impact factor: 6.725

2.  A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen-binding MSCRAMM, clumping factor A.

Authors:  Champion C S Deivanayagam; Elisabeth R Wann; Wei Chen; Mike Carson; Kanagalaghatta R Rajashankar; Magnus Höök; Sthanam V L Narayana
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

3.  Integrin targeted therapeutics.

Authors:  Melissa Millard; Srinivas Odde; Nouri Neamati
Journal:  Theranostics       Date:  2011-02-17       Impact factor: 11.556

4.  Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.

Authors:  H J Weiss; J Hawiger; Z M Ruggeri; V T Turitto; P Thiagarajan; T Hoffmann
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

5.  Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation.

Authors:  Y T Wachtfogel; W Abrams; U Kucich; G Weinbaum; M Schapira; R W Colman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.

Authors:  B S Coller; E I Peerschke; L E Scudder; C A Sullivan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets.

Authors:  P Harrison; B Wilbourn; N Debili; W Vainchenker; J Breton-Gorius; A S Lawrie; J M Masse; G F Savidge; E M Cramer
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

8.  Blood compatibility assessment of polymers used in drug eluting stent coatings.

Authors:  Luisa Mayorga Szott; Colleen A Irvin; Mikael Trollsas; Syed Hossainy; Buddy D Ratner
Journal:  Biointerphases       Date:  2016-06-15       Impact factor: 2.456

9.  Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation.

Authors:  B H Chao; J A Jakubowski; B Savage; E P Chow; U M Marzec; L A Harker; J M Maraganore
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  The platelet integrin alphaIIbbeta3 binds to the RGD and AGD motifs in fibrinogen.

Authors:  Juan Sánchez-Cortés; Milan Mrksich
Journal:  Chem Biol       Date:  2009-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.